What is the most appropriate initial management for a 53-year-old woman with diabetes mellitus and chronic kidney disease (baseline GFR 32 mL/min/1.73 m², current GFR 18 mL/min/1.73 m²) who presents with nausea, vomiting, hyperkalemia (serum potassium 6.3 mEq/L) and a normal electrocardiogram?

Initial Management: Stabilize Cardiac Membrane and Shift Potassium Intracellularly

The most appropriate initial management is to administer intravenous calcium gluconate (10 mL of 10% solution) to stabilize the cardiac membrane, followed immediately by insulin with dextrose (10 units regular insulin with 50 mL dextrose) to shift potassium intracellularly, despite the normal EKG. 1

Rationale for Urgent Treatment

This patient has severe hyperkalemia (K+ 6.3 mEq/L) with acute kidney injury (AKI) on CKD (GFR dropped from 32 to 18 mL/min/1.73 m²). While the EKG currently shows no acute changes, this does not eliminate the risk of life-threatening arrhythmias. The absence of EKG changes should not delay treatment at this potassium level 1.

Step-by-Step Acute Management Algorithm:

1. IV Calcium Gluconate (10 mL of 10%) - First-line therapy

   • Stabilizes cardiac membrane within 1-3 minutes
   • Provides immediate cardioprotection regardless of EKG findings
   • Does not lower potassium but prevents arrhythmias 1

2. IV Insulin/Glucose (10 units + 50 mL dextrose) - Immediate second step

   • Redistributes potassium to intracellular space within 30-60 minutes
   • Glucose is essential given her diabetes to prevent hypoglycemia
   • Does not eliminate total body potassium 1

3. Nebulized Salbutamol (20 mg in 4 mL) - Consider as adjunct

   • Provides additional intracellular potassium shift
   • Short duration of effect (2-4 hours)
   • Can be used concurrently with insulin/glucose 1

Addressing the Acute Kidney Injury

The patient's GFR decline from 32 to 18 mL/min/1.73 m² represents significant AKI, likely precipitated by nausea/vomiting causing volume depletion. This AKI is contributing to the hyperkalemia by reducing renal potassium excretion 2.

Additional Acute Considerations:

• Volume resuscitation: Address the prerenal component of AKI with IV fluids (normal saline) once cardiac membrane is stabilized
• Avoid diuretics initially: Patient is likely volume depleted from vomiting; diuretics would be appropriate only if hypervolemic 1
• Sodium bicarbonate: Not indicated here as there's no mention of metabolic acidosis 1

Monitoring Requirements

• Recheck potassium within 1-2 hours after initial interventions
• Continuous cardiac monitoring to detect any EKG changes
• Serial glucose monitoring given diabetes and insulin administration
• Reassess volume status and kidney function

Common Pitfalls to Avoid

1. Don't delay treatment waiting for EKG changes - Severe hyperkalemia (>6.0 mEq/L) warrants urgent treatment regardless of EKG 1
2. Don't forget glucose with insulin - Critical in diabetic patients to prevent hypoglycemia
3. Don't use diuretics in volume-depleted patients - This patient's vomiting suggests hypovolemia, not hypervolemia 1
4. Don't stop RAAS inhibitors acutely - While they may need adjustment, the immediate priority is stabilizing potassium and treating AKI 3

Short-Term Management (Next 24-48 Hours)

Once acute stabilization is achieved:

• Identify and treat precipitants: Volume depletion from vomiting, review medications
• Consider potassium binders (patiromer or sodium zirconium cyclosilicate) if hyperkalemia persists after AKI correction 1, 4
• Dietary potassium restriction counseling
• Optimize kidney function through volume resuscitation

Long-Term Considerations

After acute management, the focus shifts to preventing recurrence while maintaining cardio-renal protective medications. Hyperkalemia should be managed with potassium binders rather than discontinuing RAAS inhibitors when possible, as discontinuation is associated with worse cardiovascular and renal outcomes 3, 5. The KDIGO 2024 guidelines emphasize continuing RAAS inhibitors even with eGFR <30 mL/min/1.73 m² unless hyperkalemia is uncontrolled despite medical treatment 3.